Montserrat Perez
Cadiz, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis.
Journal: The Journal of antimicrobial chemotherapy
Published: April 08, 2018
Similar recovery of liver function after response to all-oral HCV therapy in patients with cirrhosis with and without HIV coinfection.
Journal: Journal of viral hepatitis
Published: November 20, 2017
Impact of interferon-free regimens on the glomerular filtration rate during treatment of chronic hepatitis C in a real-life cohort.
Journal: Journal of viral hepatitis
Published: July 06, 2017
Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia.
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Published: January 18, 2015
Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term.
Journal: Hepatology (Baltimore, Md.)
Published: July 26, 2014
Risk of liver decompensation among HIV/hepatitis C virus-coinfected individuals with advanced fibrosis: implications for the timing of therapy.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: August 16, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026